Find the low abundance biomarkers in your sample
Flexible workflows for every bench. Choose what works for you.
Introducing NeuXplore™
A complete solution for reliable blood based biomarker detection
Proprietary proteomics platform technology
Scalable sample-to-answer Dx system
qPCR analysis software that reports results in pg/mL
Novel technology to detect multiple low-abundance targets
Flexible solutions to enable ultrasensitivity in every lab
Reliable analysis software to report results in pg/mL
As neurodegenerative disease rates rise, the need for rapid, reliable, and accessible diagnostic tools is greater than ever. To answer this need, we have developed NeuXplore, our cost-effective, scalable, sample-to-answer platform. From biomarker validation through clinical diagnostics, our reliable instrument detects ultra-low levels of blood biomarkers, generating trusted results with quantitative outputs (i.e., pg/mL) in less than four hours.
Why choose NeuXplore?
Cost-effective, ultra-sensitive blood biomarker detection
Because of the simplicity of our technology, assays can be conducted manually via benchtop testing with a pipettor (similar to traditional ELISA). No specialized equipment is needed; just run your samples using any qPCR instrument.
Streamlined, scalable blood biomarker detection
Our high-throughput NeuXplore FDA Class II sample-to-answer benchtop instrument, allows for streamlined detection of blood biomarkers in formats of 16, 32, and 48 samples per run.
Simple assay analysis for reliable results
Our proprietary, easy-to-use software processes qPCR data from both benchtop and automated workflows, reporting quantitative, pg/mL blood biomarker panel results.
Don’t wait to streamline your blood biomarker clinical studies
Contact our team of scientific experts to discuss your trial needs